ODP saw the highest growth of 1.19% in patent filings and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of ODP‘s patent filings and grants. Buy the databook here.
ODP has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 27% filings and 75% grants. The World Intellectual Property Organization(WIPO), United States(US), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where ODP is filings its patents. Among the top granted patent authorities, ODP has 75% of its grants in United States(US) and 25% in European Patent Office(EPO).
China Investment and Industrial and Commercial Bank of China could be the strongest competitors for ODP
Patents related to healthtech and rare diseases lead ODP's portfolio
ODP has the highest number of patents in healthtech followed by, rare diseases and machine learning. For healthtech, nearly 27% of patents were filed and 22% of patents were granted in Q2 2024.
Anesthesia and respiratory devices related patents lead ODP portfolio followed by healthcare it, and orthopedic devices
ODP has highest number of patents in anesthesia and respiratory devices followed by healthcare it, orthopedic devices, image management, and financial service applications. For anesthesia and respiratory devices, nearly 14% of patents were filed and 6% of patents were granted in Q2 2024.
For comprehensive analysis of ODP's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.